Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson's Disease.

European neurology - 1 Jan 2022

Zhang Liang, Gu Lu-Yan, Dai Shao-Bing, Zheng Ran, Jin Chong-Yao, Fang Yi, Yang Wen-Yi, Tian Jun, Yin Xin-Zhen, Zhao Guo-Hua, Pu Jia-Li, Zhang Bao-Rong, Yan Ya-Ping, Chen Ying

Abstract excerpt

BACKGROUND: Growing evidence suggests important effects of body mass index (BMI) and metabolic status on neurodegenerative diseases. However, the roles of BMI and metabolic status on cognitive outcomes in Parkinson's disease (PD) may vary and are yet to be determined. METHODS: In total, 139 PD patients from the whole PD cohort in Parkinson's Progression Markers Initiative database underwent complete laboratory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Disease Progression

Share to Parkinson Disease

Share to Phenotype

Source

Identifiers

PMID: 34689144
DOI: 10.1159/000517538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson's Disease.PMID 34689144Read ↗

Cognition among individuals along a spectrum of increased risk for Parkinson's disease.Semantic proximity Read ↗

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Semantic proximity Read ↗

Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.Semantic proximity Read ↗

What can biomarkers tell us about cognition in Parkinson's disease?Semantic proximity Read ↗

Associations of metabolic obesity phenotypes with cognitive aging in middle-aged and elderly Chinese adultsSemantic proximity Read ↗

Association of metabolic obesity phenotypes with cognitive decline in the ELSA-Brasil study.Semantic proximity Read ↗

Association of cholesterol and glycemic state biomarkers with phenotypic variation and Parkinson's disease progression: The Oxford Discovery cohort.Semantic proximity Read ↗

Is metabolic-healthy obesity associated with risk of dementia? An age-stratified analysis of the Whitehall II cohort study.Semantic proximity Read ↗

Vascular Phenotyping in Parkinson’s Disease: Diabetes Mellitus Operationalizes a Microvascular Metabolic Syndrome Cluster Across PPMI Diagnostic CohortsSemantic proximity Read ↗

White matter changes and the development of motor phenotypes in de novo Parkinson's Disease.Semantic proximity Read ↗

Fat-brain axis indicated by mutual impacts between body fat and brain phenotypes.Semantic proximity Read ↗

Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.